Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study: the Efficacy of Vosevi in Treating Direct Antiviral Agent Therapy Failure Patients

NCT06180590 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT06180590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06180590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study: the Efficacy of Vosevi in Treating Direct Antiviral Agent Therapy Failure Patients
Lead sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2023
Completion date
February 28, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, medication reaction